Filter
244
Text search:
medicine
manufacturing
Featured
Recommendations
21
New Publications
48
Language
Document type
No document type
100
Studies & Reports
60
Guidelines
47
Manuals
14
Strategic & Response Plan
13
Fact sheets
4
Training Material
2
Situation Updates
2
Brochures
1
Resource Platforms
1
Countries / Regions
Kenya
12
Ghana
11
Global
8
India
7
Ethiopia
6
Zimbabwe
6
Uganda
5
Tanzania
5
Western and Central Europe
5
Nepal
4
South–East Asia Region
4
Sierra Leone
3
Philippines
3
Zambia
3
Syria
3
South Africa
3
Malawi
3
Nigeria
2
Senegal
2
Congo, Democratic Republic of
2
USA
2
Cameroon
2
Sudan
2
Botswana
2
Eastern Europe
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Pakistan
1
South Sudan
1
Germany
1
Chad
1
Cambodia
1
Rwanda
1
Benin
1
Namibia
1
Ukraine
1
Angola
1
Lesotho
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Africa
1
Tajikistan
1
Moldova
1
Turkmenistan
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
88
Clinical Guidelines
15
Public Health
14
Pharmacy & Technologies
11
Key Resources
8
Women & Child Health
3
Capacity Building
2
Toolboxes
AMR
28
COVID-19
26
Pharmacy
24
HIV
16
Planetary Health
16
TB
14
Disability
5
Mental Health
5
Specific Hazards
5
Malaria
5
Conflict
4
Global Health Education
4
NTDs
4
NCDs
4
Natural Hazards
3
Rapid Response
3
Refugee
3
Ebola & Marburg
2
Caregiver
2
2.0 Rapid Response
2
The goal of the strategy is to prevent seasonal influenza, control the spread of influenza from animals to humans, and prepare for the next influenza pandemic.
The new strategy is the most comprehensive and far-reaching that WHO has ever developed for influenza. It outlines a path to protect popul
...
Globally, approximately 56.8 million people are in need of palliative care
services; 78% of them living in low and middle-income country yet only
about 12% have their needs being met causing great suffering for many.
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
Start Free Stay Free AIDS Free - 2020 report
recommended
This progress report reviews recent gains, new developments and remaining challenges as countries approach the 2020 targets of the Start Free Stay Free AIDS Free framework.
The COVID-19 pandemic has led to large increases in healthcare waste, straining under resourced healthcare facilities and exacerbating environmental impacts from solid waste. This report quantifies the additional COVID-19 healthcare waste generated, describes current healthcare waste management syst
...
22 April 2022, This document provides updated interim recommendations on the use of masks by health workers providing care to patients with suspected or confirmed COVID-19. This update is prompted by new evidence around mask use and COVID-19 transmission, as well as the emergence of variants of conc
...
5th edition.
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response in the event of an emergency. Th
...
This operation update provides a summary of key results achieved against the IFRC Syria Complex Emergency Plan of Action covering 13-month period, from 1 June 2019 to 30 June 2020.
Pollution and health: a progress update
recommended
The Lancet Planetary Health Published:May 17, 2022DOI:https://doi.org/10.1016/S2542-5196(22)00090-0
Every year pollution causes 9 million deaths—1 in every 6 deaths worldwide, according to a Lancet Commission on pollution and health.
While the number of deaths caused by household air pollution a
...
Second Edition
AIDS Medicines and diagnostics services
July 2015
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f
...
